No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Alemtuzumab
-
Antibodies, Monoclonal / immunology*
-
Antibodies, Monoclonal / pharmacokinetics*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm / immunology*
-
Antibodies, Neoplasm / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Humans
-
Immunotherapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
-
Middle Aged
-
Recurrence
-
Vidarabine / analogs & derivatives*
-
Vidarabine / pharmacokinetics
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Alemtuzumab
-
Vidarabine
-
fludarabine